Keywords
Last Name

Veronika Wirtz, PhD, MSc

TitleAssociate Professor
InstitutionBoston University School of Public Health
DepartmentGlobal Health
Address801 Massachusetts Ave Crosstown Center
Boston MA 02118
Phone(617) 414-1440
ORCID ORCID Icon0000-0002-0863-8768
 Awards and Honors

Start-EndDescription
2009-2010Coordinating Commission of the National Institutes of Health and Tertiary Hospitals, Mexico: Excellence in Research Productivity
2009-2014National System of Researchers (SNI), National Council for Science and Technology, Mexico : Member
2007Research Conference of the National Institutes of Health and Tertiary Hospitals, Mexico: Nominee for Best Research Presentation
2007-2009National System of Researchers (SNI), National Council for Science and Technology, Mexico: Awarded Membership as Candidate
1999-2004School of Pharmacy, University of London: PhD Studies Scholarship
 Research Expertise & Professional Interests
Veronika J. Wirtz, MSc, PhD is a pharmacist, educator and researcher with over ten years of experience in international public health focusing on health system strengthening and program evaluations of medicines access and utilization. Currently, Dr. Wirtz is Associate Professor of Global Health at Boston University School of Public Health (BUSPH) where she teaches courses in health systems, pharmaceuticals in public health, and non-communicable diseases. She is a Visiting Professor of the National Institute of Public Health (INSP) in Mexico and coordinator of a student exchange program between the institutions of her affiliation.

Her interest and expertise include medicines price analysis, generic medicines policies, access to medicines for non-communicable diseases and the role of the private sector to promote equitable access and efficient use of medicines in low and middle income countries. Among other international studies Dr Wirtz carried out cross-national comparison of medicines consumption using large sales data bases to inform policy making about adequate use of medicines and prevention of antimicrobial resistance.

Recently she became the Co-Chair of The Lancet Commission on Essential Medicine Policies. The Commission has the goals of (1) re-confirming the ongoing relevance, and the crucial need of comprehensive essential medicines policies to achieve broader global health and sustainable development goals, especially universal health coverage and (2) formulating recommendations for global essential medicine policies for the next two decades. The Report of the Commission is expected to be published in 2016.

From 2004 to 2012 she was researcher and lecturer at the National Institute of Public Health (INSP) in Mexico and a founding member and Head of the Medicines in Public Health Research Group which is a multi-disciplinary team of 15 experts in health economics, epidemiology, social science carrying out pharmaceutical policy analysis in Mexico and Latin America. Over the last years she has regularly taught short courses in Pharmacoepidemiology and Medicines Utilization Research at INSP in Mexico.

She has worked as a technical advisor for various international organizations, among them the World Health Organization, the Pan American Health Organization, the Global Fund to fight AIDS, Tuberculosis and Malaria, the Bill and Melinda Gates Foundation, Alliance for Health Systems and Policy Research, Health Action International and the Ford Foundation. She has also worked with the Ministry of Health in Mexico on various program evaluations and capacity building initiatives. She published widely in international peer review journals such as The Lancet, British Medical Journal, World Health Organization Bulletin, Health Policy and Planning, Health Policy, Value in Health, Social Science and Medicine, Tropical Medicine and International Health.

She received her training as a pharmacist from Albert-Ludwigs-University in Freiburg, Germany and her Master in Clinical Pharmacy and PhD from the University of London in the UK.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85. PMID: 27217433.
    View in: PubMed
  2. Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, de Joncheere K, Pedersen HB, Dedet G, Paris V, Mantel-Teeuwisse AK, Babar ZU. Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. J Pharm Policy Pract. 2016; 9:9. PMID: 26981252.
    View in: PubMed
  3. Ashigbie PG, Azameti D, Wirtz VJ. Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study. J Pharm Policy Pract. 2016; 9:6. PMID: 26913200.
    View in: PubMed
  4. Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV. Essential medicines are still essential. Lancet. 2015 Oct 24; 386(10004):1601-3. PMID: 26595616.
    View in: PubMed
  5. Vogler S, Zimmermann N, Wirtz VJ, Babar ZU. Policy cooperation and interface issues. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E3. PMID: 26468396.
    View in: PubMed
  6. Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, Babar ZU. Challenges and opportunities for pharmaceutical pricing and reimbursement policies. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E1. PMID: 26468394.
    View in: PubMed
  7. Vogler S, Zimmermann N, Wirtz VJ, Babar ZU. Policies beyond the crisis: lesson learned. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E2. PMID: 26468395.
    View in: PubMed
  8. Servan-Mori E, Wirtz V, Avila-Burgos L, Heredia-Pi I. Antenatal Care Among Poor Women in Mexico in the Context of Universal Health Coverage. Matern Child Health J. 2015 Oct; 19(10):2314-22. PMID: 26093688.
    View in: PubMed
  9. Servan-Mori E, Heredia-Pi I, Montañez-Hernandez J, Avila-Burgos L, Wirtz VJ. Access to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage. PLoS One. 2015; 10(9):e0136823. PMID: 26407158.
    View in: PubMed
  10. Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Reply to "decrease in penicillin sales in Brazil after over-the-counter restrictions". Antimicrob Agents Chemother. 2015 Sep; 59(9):5864. PMID: 26276894.
    View in: PubMed
  11. Moucheraud C, Wirtz VJ, Reich MR. Evaluating the quality and use of economic data in decisions about essential medicines. Bull World Health Organ. 2015 Oct 1; 93(10):693-699. PMID: 26600611.
    View in: PubMed
  12. Díaz-Portillo SP, Idrovo ÁJ, Dreser A, Bonilla FR, Matías-Juan B, Wirtz VJ. [Clinics adjacent to private pharmacies in Mexico: infrastructure and characteristics of the physicians and their remuneration]. Salud Publica Mex. 2015 Jul-Aug; 57(4):320-8. PMID: 26395797.
    View in: PubMed
  13. Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015 Jul; 93(1):108-13. PMID: 25986581.
    View in: PubMed
  14. Nigenda G, Wirtz VJ, González-Robledo LM, Reich MR. . Evaluating the Implementation of Mexico's Health Reform: The Case of Seguro Popular. Health System and Reform. 2015; 3(1):217–228.
    View in: External Website
  15. Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions. Antimicrob Agents Chemother. 2015 Jan; 59(1):105-10. PMID: 25313222.
    View in: PubMed
  16. Manne-Goehler J, Ramsey JM, Salgado MO, Wirtz VJ, Reich MR. Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico. Am J Trop Med Hyg. 2014 Dec; 91(6):1125-7. PMID: 25266353.
    View in: PubMed
  17. Heredia-Pi I, Servan-Mori EE, Wirtz VJ, Avila-Burgos L, Lozano R. Obstetric care and method of delivery in Mexico: results from the 2012 National Health and Nutrition Survey. PLoS One. 2014; 9(8):e104166. PMID: 25101781.
    View in: PubMed
  18. Pérez-Cuevas R, Doubova SV, Wirtz VJ, Servan-Mori E, Dreser A, Hernández-Ávila M. Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey. BMJ Open. 2014; 4(5):e004669. PMID: 24852298.
    View in: PubMed
  19. Kaplan WA, Wirtz VJ. A research agenda to promote affordable and quality assured medicines. J Pharm Policy Pract. 2014; 7:2. PMID: 25848542.
    View in: PubMed
  20. Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HG, Wirtz VJ. Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One. 2013; 8(10):e75550. PMID: 24146761.
    View in: PubMed
  21. Van Bever E, Wirtz VJ, Azermai M, De Loof G, Christiaens T, Nicolas L, Van Bortel L, Vander Stichele R. Operational rules for the implementation of INN prescribing. Int J Med Inform. 2014 Jan; 83(1):47-56. PMID: 24168761.
    View in: PubMed
  22. Kaplan WA, Wirtz VJ, Stephens P. The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One. 2013; 8(9):e74399. PMID: 24098644.
    View in: PubMed
  23. Wirtz VJ, Vian T, Kaplan WA, Simon JL. Measuring universities' commitments to global health. Lancet. 2013 Jul 20; 382(9888):204-5. PMID: 23870527.
    View in: PubMed
  24. Galárraga O, Wirtz VJ, Santa-Ana-Tellez Y, Korenromp EL. Financing HIV programming: how much should low- and middle-income countries and their donors pay? PLoS One. 2013; 8(7):e67565. PMID: 23861772.
    View in: PubMed
  25. Wirtz VJ, Dreser A, Heredia-Pi I. [Challenges and opportunities for the development of a national pharmaceutical policy in México]. Salud Publica Mex. 2013 May-Jun; 55(3):329-36. PMID: 23912546.
    View in: PubMed
  26. Wirtz VJ, Herrera-Patino JJ, Santa-Ana-Tellez Y, Dreser A, Elseviers M, Vander Stichele RH. Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Trop Med Int Health. 2013 Jun; 18(6):665-73. PMID: 23551290.
    View in: PubMed
  27. Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013 Feb 23; 381(9867):680-9. PMID: 23410612.
    View in: PubMed
  28. Wirtz VJ, Mol PG, Verdijk J, Vander Stichele RH, Taxis K. Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009. Trop Med Int Health. 2013 Apr; 18(4):416-25. PMID: 23379471.
    View in: PubMed
  29. Leticia Avila-Burgos, Edon Serván-Mori E, Veronika J. Wirtz, Sandra G. Sosa-Rubí, Aaron Salinas-Rodríguez. Estimación del Efecto del Seguro Popular sobre el gasto en salud en hogares mexicanos a diez años de su implementación, ENSANUT 2012. Salud Publica Mexico. 2013; 55(sup 2):91-99.
  30. Hortensia Reyes Morales, Sergio Flores-Hernández, Alma L. Sauceda-Valenzuela, Jesus J. Vértiz-Ramírez, Clara Juárez-Ramírez, Veronika J. Wirtz, Ricardo Pérez-Cuevas, Mauricio Avila-Hernandez. Perception of quality of ambulatory health care services in Mexico. Salud Publica Mexico. 2013; 55(sup2):100-105.
  31. Veronika J. Wirtz, Edson Servan-Mori, Anahi Dreser, Ileana Heredia-Pi, Leticia Ávila-Burgos. Access to and expenditure on medicines in Mexico: challenges and opportunities. Salud Publica Mexico. 2013; 55(sup 2):112-122.
  32. Reyes-Morales H, Flores-Hernández S, Sauceda-Valenzuela AL, Vértiz-Ramírez Jde J, Juárez-Ramírez C, Wirtz VJ, Pérez-Cuevas R. [Users' perception about of quality ambulatory healthcare services in Mexico]. Salud Publica Mex. 2013; 55 Suppl 2:S100-5. PMID: 24626684.
    View in: PubMed
  33. Wirtz VJ, Serván-Mori E, Heredia-Pi I, Dreser A, Ávila-Burgos L. [Factor associated with medicines utilization and expenditure in Mexico]. Salud Publica Mex. 2013; 55 Suppl 2:S112-22. PMID: 24626686.
    View in: PubMed
  34. Dreser A, Vázquez-Vélez E, Treviño S, Wirtz VJ. Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health. 2012; 12:1051. PMID: 23217185.
    View in: PubMed
  35. Ruiz-Rodríguez M, Wirtz VJ, Idrovo AJ, Angulo ML. Access to medicines among internally displaced and non-displaced people in urban areas in Colombia. Cad Saude Publica. 2012 Dec; 28(12):2245-56. PMID: 23288058.
    View in: PubMed
  36. Beran D, Basey M, Wirtz V, Kaplan W, Atkinson M, Yudkin JS. On the road to the insulin centenary. Lancet. 2012 Nov 10; 380(9854):1648. PMID: 23141616.
    View in: PubMed
  37. Nguyen HT, Wirtz VJ, Haaijer-Ruskamp FM, Taxis K. Indicators of quality use of medicines in South-East Asian countries: a systematic review. Trop Med Int Health. 2012 Dec; 17(12):1552-66. PMID: 22974440.
    View in: PubMed
  38. Gómez-Dantés O, Wirtz VJ, Reich MR, Terrazas P, Ortiz M. A new entity for the negotiation of public procurement prices for patented medicines in Mexico. Bull World Health Organ. 2012 Oct 1; 90(10):788-92. PMID: 23109747.
    View in: PubMed
  39. Gutiérrez-Mendoza LM, Schwartz B, Méndez de Lira Jde J, Wirtz VJ. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico. Bull World Health Organ. 2012 Oct 1; 90(10):782-7. PMID: 23109746.
    View in: PubMed
  40. Kaplan WA, Ritz LS, Vitello M, Wirtz VJ. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010. Health Policy. 2012 Aug; 106(3):211-24. PMID: 22694970.
    View in: PubMed
  41. Wirtz VJ, Santa-Ana-Tellez Y, Servan-Mori E, Avila-Burgos L. Heterogeneous effects of health insurance on out-of-pocket expenditure on medicines in Mexico. Value Health. 2012 Jul-Aug; 15(5):593-603. PMID: 22867767.
    View in: PubMed
  42. Adesina A, Wirtz VJ, Dratler S. Reforming antiretroviral price negotiations and public procurement: the Mexican experience. Health Policy Plan. 2013 Jan; 28(1):1-10. PMID: 22375026.
    View in: PubMed
  43. Wirtz VJ, Santa-Ana-Tellez Y, Trout CH, Kaplan WA. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Health Policy Plan. 2012 Dec; 27(8):638-48. PMID: 22367770.
    View in: PubMed
  44. Luis Meave Gutierrez-Mendoza, Brian Schwartz, José de Jesús Mendez-de-Lira, Veronika J. Wirtz. Storage, distribution and dispensing of oseltamivir during the first month after the H1N1 influenza outbreak in 2009: Lessons from Mexico Lessons from the field. Bulletin of the World Health Organization. 2012; 90(10):782-787.
  45. Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, Viisainen K, Medina-Lara A, Korenromp EL. Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics. 2011 Jul; 29(7):579-99. PMID: 21671687.
    View in: PubMed
  46. Sesma-Vázquez S, Gómez-Dantés O, Wirtz VJ, Castro-Tinoco M. [Supply prescription filling and out-of-pocket expenditures on medicines in public hospitals in Mexico in 2009]. Salud Publica Mex. 2011; 53 Suppl 4:470-9. PMID: 22282209.
    View in: PubMed
  47. Anahi Dreser, Veronika J. Wirtz, Yared Santa Ana Téllez. Consumo de antibacterianos en América Latina: la importancia de analizar sus causas e implicaciones. La Gazeta de Infectología y Microbiología Cliníca Latinoamericano. 2011; 1(2):36-41.
  48. Bautista-Arredondo S, Wirtz VJ, Bertozzi SM. Improving access to treatment for HIV in sub-Saharan Africa. BMJ. 2010; 341:c6546. PMID: 21123343.
    View in: PubMed
  49. Sauceda-Valenzuela AL, Wirtz VJ, Santa-Ana-Téllez Y, de la Luz Kageyama-Escobar M. Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico. BMC Health Serv Res. 2010; 10:178. PMID: 20573225.
    View in: PubMed
  50. Bautista-Arredondo S, Martz TE, Wirtz VJ, Bertozzi SM. Optimizing HIV treatment programs. Curr Opin HIV AIDS. 2010 May; 5(3):232-6. PMID: 20539079.
    View in: PubMed
  51. Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Rev Panam Salud Publica. 2010 Mar; 27(3):219-25. PMID: 20414511.
    View in: PubMed
  52. Wirtz VJ, Russo G, Kageyama-Escobar Mde L. Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006. Salud Publica Mex. 2010 Jan-Feb; 52(1):30-8. PMID: 20464251.
    View in: PubMed
  53. Wirtz VJ, Forsythe S, Valencia-Mendoza A, Bautista-Arredondo S. Factors influencing global antiretroviral procurement prices. BMC Public Health. 2009; 9 Suppl 1:S6. PMID: 19922690.
    View in: PubMed
  54. Gutiérrez-Luna A, Angeles-Llerenas A, Wirtz VJ, Del Río AA, Zamilpa-Mejía L, Aranda-Flores C, Viramontes JL, Lazcano-Ponce E. Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico. Clin Trials. 2009 Aug; 6(4):365-72. PMID: 19625328.
    View in: PubMed
  55. Wirtz VJ, Dreser A, Leyva R. [The debate on self medication]. Salud Publica Mex. 2009 May-Jun; 51(3):179-80. PMID: 19967299.
    View in: PubMed
  56. Wirtz VJ, Taxis K, Dreser A. Pharmacy customers' knowledge of side effects of purchased medicines in Mexico. Trop Med Int Health. 2009 Jan; 14(1):93-100. PMID: 19017308.
    View in: PubMed
  57. Ruiz-Rodríguez M, Wirtz VJ, Nigenda G. Organizational elements of health service related to a reduction in maternal mortality: the cases of Chile and Colombia. Health Policy. 2009 May; 90(2-3):149-55. PMID: 18995922.
    View in: PubMed
  58. Gonzales R, Corbett KK, Wirtz V, Dreser A. Drug Resistant Infections in Poor Countries: A shrinking window of opportunity. BMJ. 2008 Apr 26; 336(7650):948-9. PMID: 18397943.
    View in: PubMed
  59. Wirtz VJ, Reich MR, Hernández-Avila M. [Research to support pharmaceutical policies]. Salud Publica Mex. 2008; 50 Suppl 4:S427-8. PMID: 19082252.
    View in: PubMed
  60. Dreser A, Wirtz VJ, Corbett KK, Echániz G. [Antibiotic use in Mexico: review of problems and policies]. Salud Publica Mex. 2008; 50 Suppl 4:S480-7. PMID: 19082259.
    View in: PubMed
  61. Wirtz VJ, Reich MR, Leyva Flores R, Dreser A. Medicines in Mexico, 1990-2004: systematic review of research on access and use. Salud Publica Mex. 2008; 50 Suppl 4:S470-9. PMID: 19082258.
    View in: PubMed
  62. Ralph Gonzalez, Kitty Corbett, Veronika J. Wirtz, Anahi Dreser. Quality improvement interventions for resistant infections in developing countries. A shrinking window of opportunity. British Medical Journal. 2008; 336:948-49.
  63. Angeles-Llerenas AR, Wirtz V, Lara-Alvarez CF. The role and responsibilities of witnesses in the informed consent process. Dev World Bioeth. 2009 Apr; 9(1):18-25. PMID: 18370932.
    View in: PubMed
  64. Veronika Wirtz, Alan Cribb, Nick Barber. The use of informed consent for mediation treatment in hospital – qualitative study of the views of doctors and nurses. Clinical Ethics. 2007; 2(1):36-41.
  65. Wirtz V, Cribb A, Barber N. Patient-doctor decision-making about treatment within the consultation--a critical analysis of models. Soc Sci Med. 2006 Jan; 62(1):116-24. PMID: 15992980.
    View in: PubMed
  66. Wirtz V, Cribb A, Barber N. Reimbursement decisions in health policy--extending our understanding of the elements of decision-making. Health Policy. 2005 Sep 8; 73(3):330-8. PMID: 16039351.
    View in: PubMed
  67. Veronika Wirtz, Alan Cribb, Nick Barber. Reimbursement decision in health policy – extending our understanding of the elements of decision-making. Health Policy. 2005; 73:330-338.
  68. Taxis K, Wirtz V, Barber N. Variations in aseptic techniques during preparation and administration of intravenous drugs-an observation-based study in the UK and in Germany. J Hosp Infect. 2004 Jan; 56(1):79-81. PMID: 14706281.
    View in: PubMed
  69. Wirtz V, Cribb A, Barber N. Understanding the role of "the hidden curriculum" in resource allocation--the case of the UK NHS. Health Care Anal. 2003 Dec; 11(4):295-300. PMID: 14769011.
    View in: PubMed
  70. Wirtz V, Taxis K, Barber ND. An observational study of intravenous medication errors in the United Kingdom and in Germany. Pharm World Sci. 2003 Jun; 25(3):104-11. PMID: 12840963.
    View in: PubMed
Veronika's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department